COMMUNIQUÉS West-GlobeNewswire

Biomea Fusion to Participate at Upcoming Investor Conferences
12/05/2026
SAN CARLOS, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that management will participate in [...]
To Your Health Launches Innovative Online Protein Intake Calculator
12/05/2026
New Science-Based Tool Aims to Prevent Muscle Loss and Maintain Bone Density in Middle-Aged Women and Aging Adults Wallingford, CT, May 12, 2026 (GLOBE NEWSWIRE) -- TO YOUR HEALTH, a leader in personalized nutrition and [...]
ATUM’s New Lock-In Platform Solves Bispecific Mispairing
12/05/2026
The Platform Addresses a Key Bottleneck in Multispecific Antibody Engineering NEWARK, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- ATUM, a global leader in bioengineering and cell line development, today announced the [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
12/05/2026
Company Announcement COPENHAGEN, Denmark; May 12, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 2,346 shares as a consequence of the exercise of employee warrants. The increase is effected without [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
12/05/2026
Nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
Rosewood STEM Magnet’s Year of National Honors Draws Recognition from McComb Orthodontics West Hollywood
12/05/2026
Ryan McComb of McComb Orthodontics West Hollywood with Friends of Rosewood STEM Elementary Board Member Katie Pisciotta, Co-President Jasmin Patterson, Board Member Ava Surkes, Co-President Anne Ramallo, Board Member [...]
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
12/05/2026
WARREN, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced that it has entered into a securities purchase agreement for a private investment in [...]
High Diet Surpasses 1,700 Customer Reviews as Users Praise Personalized High-Protein Meal Plans
12/05/2026
1,700+ customer reviews point to High Diet's personalized high-protein meal plans and fitness tracking as the features keeping users coming back NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- High Diet has launched a [...]
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2%
12/05/2026
Consolidated net revenue of € 713.4 million in the first quarter of 2026, +4.9% or +8.7% on a like-for-like basis (3) at constant exchange rates (CER); adverse FX impact of € 29.1 million (-4.3%) EBITDA (1) of € 283.6 [...]
UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
12/05/2026
CBeyond™ Expansion Study (Part C) initiated; Cohort Review Committee review scheduled for May 18, 2026, to evaluate available safety data and potential progression to Cohort 2 SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE [...]
Minutes of the General Meeting of 12 May 2026
12/05/2026
Minutes of the General Meeting of 12 May 2026 Paris, 12 May 2026 – The Annual General Meeting of shareholders of Clariane (CLARI - ISIN: FR0010386334) was held on 12 May 2026 (the « General Meeting »), chaired by Sylvia [...]
Compte-rendu de l’Assemblée Générale du 12 Mai 2026
12/05/2026
Compte rendu de l’Assemblée générale du 12 mai 2026 Paris, le 12 mai 2026 – L’Assemblée générale annuelle des actionnaires de la société Clariane (CLARI - ISIN : FR0010386334) s’est réunie le 12 mai 2026 (l’« Assemblée [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
12/05/2026
Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026
12/05/2026
NEW YORK, 12 mai 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa plateforme pionnière d’édition du génome pour développer des [...]
SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform
12/05/2026
Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include paid advertising. NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) [...]
Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets
12/05/2026
Patent reinforces strategic foundation for lead ADC AKTX-101 and expanding ADC pipeline to new molecules targeting high-value oncology indications TAMPA, Fla. and LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- Akari [...]
20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina
12/05/2026
Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test Results Licensing Agreement Expands 20/20 BioLabs’ AI-Enabled Multi-Cancer Early Detection Platform [...]
ENvue Medical Secures Three-Year Contract Renewal at 12-Hospital U.S. Health Network as the ENvue™ Navigation Platform Becomes Standard of Care
12/05/2026
ENvue™ Navigation Platform adopted as the standard of care for bedside feeding tube placement across the integrated health network TYLER, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc . (NASDAQ: FEED) (“ [...]
Fortis Life Sciences Awards 2026 AbNano® VHH Discovery Grant to Deliver Biosciences for Targeted Drug Delivery Research
12/05/2026
Grant program expands access to advanced single-domain antibody technologies to support the research and development of next-generation therapies BOSTON and LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- Fortis Life Sciences [...]

Pages